Vishal Rajput – Chemtatva Chiral Solutions (Ccs) Private Limited
View Detailed Executive Profile →Professional Overview
- Vishal Rajput is the Founder and CEO of Chemtatva Chiral Solutions Private Limited, a position set to commence on February 1, 2024.
- Prior to establishing Chemtatva, Vishal served as the Vice President of Business Development at TCG Lifesciences Pvt Ltd. from March 2022 until January 2024, contributing to strategic growth initiatives within the organization.
- From December 2020 to March 2022, Vishal held the role of Head of Global CDMO Business for API and Formulations at SHILPA MEDICARE LTD, overseeing operations and developing business strategies across multiple markets.
- In a previous role as Associate General Manager of Global Business Development at Syngene International Limited from June 2019 to June 2020, Vishal led initiatives to expand the company's global outreach.
- Between April 2016 and June 2019, Vishal worked as a Senior API Specialist for Asia Pacific at Merck Life Science, where responsibilities included building client relationships and driving sales growth.
- Vishal began their career at Merck Life Science in February 2015 as a Business Development Manager for Process Solutions, providing insights that influenced future product offerings.
- In 2013, Vishal served as Group Leader at Neuland Laboratories Limited in Hyderabad, India, managing projects that contributed to portfolio development and strengthening market position.
- Prior experience includes a scientific leadership role at GVK Biosciences, serving as a team leader from July 2012 to November 2013, where direct contributions to scientific research were made.
- Vishal's career began as a Research Scientist at Jagsonpal Pharmaceuticals Limited from May 2005 to November 2005, providing foundational experience in pharmaceutical research and development.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| Neuland Laboratories Limited | Group Leader and Portfolio Management at Neuland Labs Hyderabad, India | Nov 2013 – Feb 2015 |
| Jagsonpal Pharmaceuticals Limited | Research Scientist | May 2005 – Nov 2005 |
| TCG Lifesciences Pvt Ltd. | Vice President- Business Development | Mar 2022 – Jan 2024 |
| Syngene International Limited | Associate General Manager- Global Business Development | Jun 2019 – Nov 2020 |
| GVK Biosciences | Scientist (Team Leader) | Jul 2012 – Nov 2013 |
| Merck Life Science | Business Development Manager: Process Solutions-Merck (Formerly known SAFC) | Feb 2015 – Mar 2016 |
| SHILPA MEDICARE LTD | Head Global CDMO Business- API and Formulations | Dec 2020 – Mar 2022 |
| Merck Life Science | Senior API specialist- Asia Pacific (Sales) | Apr 2016 – Jun 2019 |
| Chemtatva Chiral Solutions Private Limited | Founder & CEO | Feb 2024 – Present |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Chemtatva Chiral Solutions (Ccs) Private Limited corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Vishal Rajput's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Chemtatva Chiral Solutions (Ccs) Private Limited's official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)